Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.

$449.7M

Market Cap • 12/25/2024

1998

(26 years)
Founded

2006

(18 years ago)
IPO

NYSE

Listing Exchange
Flag of US

Gaithersburg

Headquarters • Maryland